메뉴 건너뛰기




Volumn 55, Issue 1, 2010, Pages 137-143

Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload

Author keywords

Cardiac hypertrophy; ERK; Hypertension; Leukocytes; MAPKs

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1;

EID: 73849151773     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.135467     Document Type: Article
Times cited : (25)

References (14)
  • 2
    • 33748538992 scopus 로고    scopus 로고
    • Targeted inhibition of phospho-inositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure
    • Perrino C, Rockman HA, Chiariello M. Targeted inhibition of phospho-inositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Vascul Pharmacol. 2006; 45:77-85.
    • (2006) Vascul Pharmacol , vol.45 , pp. 77-85
    • Perrino, C.1    Rockman, H.A.2    Chiariello, M.3
  • 3
    • 0035853147 scopus 로고    scopus 로고
    • Cardiac overexpression of a G(q)inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload
    • Esposito G, Prasad SV, Rapacciuolo A, Mao L, Koch WJ, Rockman HA. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation. 2001;103:1453-1458.
    • (2001) Circulation , vol.103 , pp. 1453-1458
    • Esposito, G.1    Prasad, S.V.2    Rapacciuolo, A.3    Mao, L.4    Koch, W.J.5    Rockman, H.A.6
  • 6
    • 33745185351 scopus 로고    scopus 로고
    • Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
    • Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, Smithies O, Rockman HA. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest. 2006;116:1547-1560.
    • (2006) J Clin Invest , vol.116 , pp. 1547-1560
    • Perrino, C.1    Naga Prasad, S.V.2    Mao, L.3    Noma, T.4    Yan, Z.5    Kim, H.S.6    Smithies, O.7    Rockman, H.A.8
  • 7
    • 0025311528 scopus 로고
    • Peripheral adrenergic receptors in hypertension
    • Michel MC, Brodde OE, Insel PA. Peripheral adrenergic receptors in hypertension. Hypertension. 1990;16:107-120.
    • (1990) Hypertension , vol.16 , pp. 107-120
    • Michel, M.C.1    Brodde, O.E.2    Insel, P.A.3
  • 8
    • 0025873338 scopus 로고
    • Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy
    • Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A. 1991;88: 8277-8281.
    • (1991) Proc Natl Acad Sci U S A , vol.88 , pp. 8277-8281
    • Rockman, H.A.1    Ross, R.S.2    Harris, A.N.3    Knowlton, K.U.4    Steinhelper, M.E.5    Field, L.J.6    Jr, R.J.7    Chien, K.R.8
  • 9
    • 3042833801 scopus 로고    scopus 로고
    • Genetic factors in cardiac hypertrophy
    • Dorn GW II, Hahn HS. Genetic factors in cardiac hypertrophy. Ann N Y Acad Sci. 2004;1015:225-237.
    • (2004) Ann N y Acad Sci , vol.1015 , pp. 225-237
    • Dorn Ii, G.W.1    Hahn, H.S.2
  • 10
    • 34248591612 scopus 로고    scopus 로고
    • Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
    • Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26: 3291-3310.
    • (2007) Oncogene , vol.26 , pp. 3291-3310
    • Roberts, P.J.1    Der, C.J.2
  • 11
    • 34548858159 scopus 로고    scopus 로고
    • Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease
    • Clark JE, Sarafraz N, Marber MS. Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacol Ther. 2007;116: 192-206.
    • (2007) Pharmacol Ther , vol.116 , pp. 192-206
    • Clark, J.E.1    Sarafraz, N.2    Marber, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.